Tradename: ProQuad
Proper Name: Measles, Mumps, Rubella and Varicella Virus Vaccine Live
Indication: To include safety and immunogenicity data that supports the intramuscular route as an additional route of administration for ProQuad, and associated product labeling changes.
ProQuad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age.
Approval Date: 02/27/2023
Manufacturer: Merck Sharp & Dohme Corp.
More: https://www.fda.gov/vaccines-blood-biologics/vaccines/proquad